| Literature DB >> 36039285 |
Tom E Hardwicke1, Robert T Thibault2,3, Jessica E Kosie4, Loukia Tzavella5, Theiss Bendixen6, Sarah A Handcock7, Vivian E Köneke8, John P A Ioannidis2,9,10.
Abstract
Journals exert considerable control over letters, commentaries and online comments that criticize prior research (post-publication critique). We assessed policies (Study One) and practice (Study Two) related to post-publication critique at 15 top-ranked journals in each of 22 scientific disciplines (N = 330 journals). Two-hundred and seven (63%) journals accepted post-publication critique and often imposed limits on length (median 1000, interquartile range (IQR) 500-1200 words) and time-to-submit (median 12, IQR 4-26 weeks). The most restrictive limits were 175 words and two weeks; some policies imposed no limits. Of 2066 randomly sampled research articles published in 2018 by journals accepting post-publication critique, 39 (1.9%, 95% confidence interval [1.4, 2.6]) were linked to at least one post-publication critique (there were 58 post-publication critiques in total). Of the 58 post-publication critiques, 44 received an author reply, of which 41 asserted that original conclusions were unchanged. Clinical Medicine had the most active culture of post-publication critique: all journals accepted post-publication critique and published the most post-publication critique overall, but also imposed the strictest limits on length (median 400, IQR 400-550 words) and time-to-submit (median 4, IQR 4-6 weeks). Our findings suggest that top-ranked academic journals often pose serious barriers to the cultivation, documentation and dissemination of post-publication critique.Entities:
Keywords: journal policy; letter to the editor; meta-research; peer review; post-publication critique; scientific criticism
Year: 2022 PMID: 36039285 PMCID: PMC9399707 DOI: 10.1098/rsos.220139
Source DB: PubMed Journal: R Soc Open Sci ISSN: 2054-5703 Impact factor: 3.653
Figure 1Number and percentage of journals offering any (purple) and specific (green) options for post-publication critique (PPC) in all scientific disciplines (top-left panel, n = 330 journals) and in individual scientific disciplines (other panels, n = 15 journals). Note that individual journals can offer multiple post-publication critique options.
Post-publication critique types and their length, time-to-submit, or reference limits. The table shows the number (n) and percentage (%) of post-publication critique types that are subject to any (qualitative or quantitative) limit, quantitative limits specifically, and the median (Md) and interquartile range (IQR) for quantitative limits. The table also shows whether the author submission guidelines state that the post-publication critique types are sent for independent external peer review either routinely or at the editor's discretion (for details see electronic supplementary material, SH).
| post-publication critique type | length limits | time-to-submit limits | reference limits | peer review | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| any | quantitative | any | quantitative | any | quantitative | |||||
| Md words (IQR) | Md weeks (IQR) | Md refs (IQR) | ||||||||
| letters ( | 92 (78%) | 92 (78%) | 500 (513) | 50 (42%) | 39 (33%) | 8 (22) | 68 (58%) | 65 (55%) | 6 (5) | 24 (20%) |
| commentaries ( | 62 (73%) | 59 (69%) | 1200 (300) | 25 (29%) | 10 (12%) | 26 (26) | 41 (48%) | 38 (45%) | 15 (0) | 47 (55%) |
| web comments ( | 11 (27%) | 10 (24%) | 600 (75) | 5 (12%) | 0 (0%) | — | 2 (5%) | 2 (5%) | 8 (3) | 0 (0%) |
| other ( | 2 (33%) | 1 (17%) | 10 000 (0) | 0 (0%) | 0 (0%) | — | 1 (17%) | 0 (0%) | — | 3 (50%) |
| all types ( | 167 (67%) | 162 (65%) | 1000 (700) | 80 (32%) | 49 (20%) | 12 (22) | 112 (45%) | 105 (42%) | 10 (10) | 74 (30%) |
Figure 2Limits imposed by journals on post-publication critique (PPC) in terms of (a) length and (b) time-to-submit since publication of the target article. A1 and B1 show the number of post-publication critique options for which the journal did not state if there was a limit (Not stated), explicitly stated there was not a limit (None), stated a qualitative limit (Qual) or stated a quantitative limit (Quant). Quantitative limits are displayed in A2 and B2 as a histogram and boxplot with the dark line representing the median, lower and upper hinges representing the 25th and 75th percentiles, and upper and lower whiskers representing the ±1.5 interquartile range.
Twenty journals that offered the most restrictive options for post-publication critique. Journals were selected based on having the most restrictive quantitative length and time-to-submit limits for at least one of their post-publication critique options. Some of these journals also offered additional less restrictive options, which we have included and marked with asterisks. When post-publication critiques were subject to qualitative limits, the verbatim policy text is shown. Journals are presented in alphabetical order. Journal of the American Medical Association (JAMA) journals are clustered because they had identical post-publication critique policies.
| journal | post-publication critique type | length limit (words) | time-to-submit limit |
|---|---|---|---|
| Annals of Internal Medicine | letters | 400 | four weeks |
| web commentsa | Not specified | not specified | |
| Annals of Neurology | letters | 400 | not specified |
| Clinical Pharmacology and Therapeutics | letters | 400 | six months |
| Emerging Infectious Diseases | letters | 300 | four weeks |
| web commentsa | 1667 | not specified | |
| JAMA, JAMA Internal Medicine, JAMA Neurology, JAMA Oncology, JAMA Psychiatry | letters | 400 | four weeks |
| web comments | 600 | 'We may reject comments because they…are submitted a long time after article publication' | |
| Journal of the Royal Statistical Society Series B-Statistical Methodology | letters | 400 | 1 year |
| Lancet | letters | 250 | two weeks |
| Lancet Diabetes and Endocrinology | letters | 400 | eight weeks |
| Lancet HIV | letters | 250 | four weeks |
| Lancet Infectious Diseases | letters | 400 | six weeks |
| Lancet Psychiatry | letters | 400 | four weeks |
| Lancet Respiratory Medicine | letters | 400 | four weeks |
| National Science Review | letters | 300 | not specified |
| Neurology | letters | 200 | '…restricted to comments about studies published in Neurology within the past eight weeks, with the exception of submissions identifying possible errors in data or data analysis, or by appeal to the Editor' |
| New England Journal of Medicine | letters | 175 | three weeks |
| web comments | 200 | not specified | |
| Science | letters | 300 | three months |
| web commentsa | ‘…brief…’ | not specified | |
| commentariesa | 1000 | three months |
aJournals are included in the table based on having the most restrictive post-publication critique options; however, for each journal, we have also included all other options for post-publication critique they offered and marked them with asterisks.
Figure 3Primary (a) and secondary (b) prevalence estimates for post-publication critique in all journals overall (N = 330 journals; black diamond, error bars represent 95% confidence intervals) and then in descending order by each scientific discipline (n = 15 journals; coloured circles). Discipline abbreviations: Agricultural Sciences (AGRI), Biology and Biochemistry (BIO), Chemistry (CHEM), Clinical Medicine (MED), Computer Science (COMSCI), Economics and Business (ECON), Engineering (ENGIN), Environment and Ecology (ECO), Geosciences (GEO), Immunology (IMMUN), Materials Science (MATSCI), Mathematics (MATH), Microbiology (MICBIO), Molecular Biology and Genetics (MOLBIO), Multidisciplinary (MULTI), Neuroscience and Behaviour (NEURO), Pharmacology and Toxicology (PHARM), Physics (PHYS), Plant and Animal Science (PLANT), Psychiatry and Psychology (PSY), Social Sciences (SOCSCI), Space Science (SPACE).
Features of 58 assessed post-publication critiques. NC, not calculable (because n = 1).
| commentaries | 1 | |||
| web comments | 13 | |||
| letters | 44 | |||
| New England Journal of Medicine | 18 | |||
| JAMA | 6 | |||
| Lancet Psychiatry | 6 | |||
| The BMJ | 4 | |||
| Lancet Oncology | 3 | |||
| Current Biology | 2 | |||
| Gastroenterology | 2 | |||
| Neurology | 2 | |||
| Science | 2 | |||
| 13 other journals | 1 | |||
| Clinical Medicine | 35 | |||
| Psychiatry and Psychology | 8 | |||
| Multidisciplinary | 5 | |||
| Biology and Biochemistry | 4 | |||
| Neuroscience and Behavior | 4 | |||
| Immunology | 1 | |||
| Molecular Biology and Genetics | 1 | |||
| target paywalled, post-publication critique paywalled | 22 | |||
| target public, post-publication critique public | 19 | |||
| target paywalled, post-publication critique public | 10 | |||
| target public, post-publication critique paywalled | 7 | |||
| not anonymous | 57 | |||
| anonymous | 1 | |||
| statement declares no COI | 30 | |||
| statement declares COI | 15 | |||
| no COI statement | 13 | |||
| design | 19 | |||
| implementation | 3 | |||
| analysis | 19 | |||
| reporting | 10 | |||
| interpretation | 45 | |||
| ethics (other) | 1 | |||
| no data availability statement | 43 | |||
| data sharing not applicable | 7 | |||
| statement says data are available upon request | 5 | |||
| statement says data are available | 3 | |||
| no analyses or data | 51 | |||
| novel analyses of new data | 5 | |||
| novel analyses of original data | 1 | |||
| novel analyses of original and new data | 1 | |||
| letters | 251 | 104 | 1420 | 177 |
| commentaries | 1586 | 1586 | 1586 | NC |
| web comments | 108 | 9 | 993 | 309 |
| all types | 251 | 9 | 1586 | 199 |
| letters | 133 | 21 | 1053 | 86 |
| commentaries | 525 | 525 | 525 | NC |
| web comments | 63 | 5 | 1066 | 789 |
| all types | 133 | 5 | 1066 | 112 |
Features of target article author response to 58 assessed post-publication critiques.
| no | 56 |
| yes | 2 |
| yes | 44 |
| no | 14 |
| no | 42 |
| yes | 2 |
| no | 40 |
| yes | 4 |
| yes | 41 |
| no | 3 |